Matthew Stober Founder of Abzena Backed byBiospring PartnersJennifer Lum SourcesAbzena Launches EpiScreen® 2.0, a Next Generation Immunogenicity Tool for De-Risking the Development of Complex Biologics and Bioconjugates — 2022-03 Browse all founders · Browse investors
